Search

everythinglearnresearchcommunity

for

Search:↓

PCOS treatment should be personalized based on its type and the patient's reproductive goals.

Melanoma risk tools need improvement, a gene mutation causes a hair disorder that might be treated by managing cell stress, a potential therapy for a skin-ear disorder involves blocking cell channels, skin wrinkling may indicate lung aging regardless of smoking, and oxidative stress might contribute to common baldness.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Removing a methyl group from the ITGAV gene speeds up bone formation in a specific type of bone disease model.

Exosomes show promise for tissue repair and regeneration with advantages over traditional cell therapies.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

PRP, exosomes, and physical therapies show promise for hair and tissue repair, but need more research for optimization.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

New techniques have enhanced our understanding of how stem cells function and the role of mutations in aging tissues, which may influence future cancer therapies.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

Extracts from three Polynesian plants were found to promote hair growth by affecting cell growth and gene expression related to hair.

Alopecia Areata has no cure, treatments are limited, and the condition often recurs, but new therapies like JAK inhibitors show promise.

The nucleus is key in controlling skin growth and repair by coordinating signals, gene regulators, and epigenetic changes.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Thymosin beta 4 protects cells from damage by blocking a harmful microRNA and boosting a protective gene.

Smart delivery methods for CRISPR gene editing are crucial for clinical success.

Developing microRNA-based treatments is hard but has potential.

EDA2R is a key gene linked to ageing and diseases, and targeting it may help treat conditions like hair loss and chronic diseases.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Progesterone treatment improved seizures in a woman with menstrual cycle-related epilepsy, but a wrong medication worsened her condition.

Turning off a specific gene in stem cells speeds up skin healing by helping cells move better.

Neuroimaging suggests that treatments targeting brain steroids could help control epilepsy, especially types linked to the menstrual cycle.

Stem cell therapies could be a promising alternative for hair loss treatment, but more research is needed to understand their full potential and safety.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

Rumex japonicus extract may promote hair growth more effectively than Minoxidil.

Chronic autoimmune urticaria can be managed with specific therapies and requires improved diagnosis and treatment methods.

Equine hoof progenitor cells can help develop therapies for hoof diseases like laminitis.

CRISPR gene editing reduces harmful molecules in cells from Emery–Dreifuss Muscular Dystrophy patients.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Turning off the Lhx2 gene in mouse embryos leads to slower wound healing and scars.